Shaanxi Panlong Pharmaceutical Group Limited By Share Future Growth
Future criteria checks 2/6
Shaanxi Panlong Pharmaceutical Group Limited By Share is forecast to grow revenue at 34.1% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 19.0% |
Revenue growth rate | 34.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 Nov 2023 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,824 | N/A | N/A | 130 | 2 |
12/31/2024 | 1,465 | N/A | N/A | 144 | 2 |
3/31/2024 | 965 | 120 | 96 | 166 | N/A |
12/31/2023 | 981 | 110 | 42 | 104 | N/A |
9/30/2023 | 997 | 107 | 43 | 93 | N/A |
6/30/2023 | 1,043 | 111 | 66 | 113 | N/A |
3/31/2023 | 1,001 | 103 | 33 | 87 | N/A |
12/31/2022 | 974 | 101 | 70 | 125 | N/A |
9/30/2022 | 958 | 98 | 77 | 149 | N/A |
6/30/2022 | 917 | 96 | 73 | 151 | N/A |
3/31/2022 | 911 | 96 | 68 | 151 | N/A |
1/1/2022 | 887 | 93 | 35 | 116 | N/A |
9/30/2021 | 842 | 86 | 46 | 136 | N/A |
6/30/2021 | 834 | 89 | 28 | 114 | N/A |
3/31/2021 | 764 | 87 | -2 | 76 | N/A |
12/31/2020 | 670 | 79 | 21 | 92 | N/A |
9/30/2020 | 626 | 80 | 5 | 72 | N/A |
6/30/2020 | 565 | 66 | -1 | 52 | N/A |
3/31/2020 | 571 | 70 | 38 | 79 | N/A |
12/31/2019 | 611 | 72 | 34 | 68 | N/A |
9/30/2019 | 587 | 76 | 35 | 57 | N/A |
6/30/2019 | 564 | 72 | 41 | 61 | N/A |
3/31/2019 | 516 | 67 | 33 | 53 | N/A |
12/31/2018 | 489 | 65 | 27 | 47 | N/A |
9/30/2018 | 442 | 57 | 22 | 36 | N/A |
6/30/2018 | 424 | 56 | 11 | 22 | N/A |
3/31/2018 | 404 | 46 | 19 | 30 | N/A |
12/31/2017 | 377 | 44 | N/A | 28 | N/A |
9/30/2017 | 369 | 49 | N/A | 41 | N/A |
6/30/2017 | 333 | 44 | N/A | 62 | N/A |
3/31/2017 | 305 | 40 | N/A | 52 | N/A |
12/31/2016 | 305 | 40 | N/A | 62 | N/A |
12/31/2015 | 256 | 43 | N/A | 41 | N/A |
12/31/2014 | 246 | 40 | N/A | 49 | N/A |
12/31/2013 | 227 | 33 | N/A | 25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 002864's forecast earnings growth is above the savings rate (2.9%).
Earnings vs Market: Insufficient data to determine if 002864's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 002864's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 002864's revenue (34.1% per year) is forecast to grow faster than the CN market (14.7% per year).
High Growth Revenue: 002864's revenue (34.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 002864's Return on Equity is forecast to be high in 3 years time